Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

DOAC dosing in obesity: a closer look at the bigger picture


This CE will provide pharmacists with knowledge on ensuring optimal medication therapy outcomes and patient safety for obese patients requiring anticoagulation for venous thromboembolism or atrial fibrillation; Satisfying educational requirements for pharmacist re-licensure

 

 

Remote attendees can attend this presentation through Zoom https://zoom.us/j/8461352508

                                                                                                                   

Please mute your microphone upon entry into the meeting room.  

Date: Jun 1, 2022 05:30 PM - 06:30 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Jun 30, 2022 05:00 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
 
Shenandoah University Bernard J. Dunn School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

To receive credit the following items must be completed

 
1. Register for the event through supharmacy.learningexpressce.com
2. Attend the entire activity
3. Complete all relevant learning assessments
4. Complete an activity evaluation through supharmacy.learningexpressce.com 

Support/Credits

No external funding has been obtained for this activity. The speakers have no conflicts of interest to disclose.

 

 

Registration closes on Jun 30, 2022 at 05:00 PM

Registration Closed  

Objectives

  • Review the literature for the use of direct oral anticoagulants (DOACs) in obese patients with venous thromboembolism (VTE) and atrial fibrillation (AF)
  • Recommend appropriate agents for the treatment of VTE and stroke prophylaxis in AF for obese patients
  • Identify current guideline recommendations and updates
  • Distinguish inappropriate use of anti-FXa monitoring

Speaker(s)/Author(s)

Matthew Brooks
PGY1 Pharmacy Resident


Brief Bio : Matthew Brooks, PharmD, MS is a PGY1 pharmacy practice resident at Winchester Medical Center in Winchester, VA. Dr. Brooks completed his Doctor of Pharmacy degree at West Virginia University in 2021. His professional interests include hospital pharmacy and internal medicine. In his spare time, Dr. Brooks enjoys spending time with his fiancé, family, and friends, as well as exploring the surrounding areas and doing all things outdoors!

Activity Number

0101-0000-22-005-L01-P
Date: 06/01/22
Time: 05:30 PM - 06:30 PM

CE Hours

1.00
Registration Closed